Date：21 July (Wednesday)
Time: 09:00 – 12:10 (GMT+8)
Li Ka Shing Applied Virology Institute
Michael Houghton BSc ( University of East Anglia, UK ) PhD ( King’s College, University of London, UK ) is the Director of the Li Ka Shing Applied Virology Institute in the University of Alberta and is the Li Ka Shing Professor within the Department of Medical Microbiology & Immunology in the Faculty of Medicine and Dentistry. He took up a Canada Excellence in Research Chair (CERC) in Virology at the University of Alberta in 2010. Working with Lorne Tyrrell MD PhD OC ( founder of the Li Ka Shing Institute of Virology ) and a large network of collaborating leaders, he is involved in developing vaccines against HCV & Group A Streptococcus as well as therapeutics for Cytomegalovirus, Alzheimer’s, Non-alcoholic fatty liver disease, & cancer oncolytics & immunotherapies. Previously he worked as a Vice-President Research in Novartis and Chiron Corporation in California where he and Chiron colleagues, Drs Qui-Lim Choo & George Kuo in collaboration with Dr Bradley of the CDC, discovered the hepatitis C virus (HCV) in 1989 for which he was a co-recipient of the Nobel prize in Medicine in 2020. He is committed to researching diseases with unmet medical need in order to improve healthcare.